Velarion Records
Free. Unsubscribe any time.

Neumora Therapeutics, Inc. (NMRA)

Neumora Therapeutics, Inc. filed 7 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 7 transactions and 154,215 shares. 7 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Neumora Therapeutics, Inc. 7

Adoption dates in Neumora Therapeutics, Inc. 5

Results prints in Neumora Therapeutics, Inc. 0

Trades before a print in Neumora Therapeutics, Inc. 0

Interval to Neumora Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Neumora Therapeutics, Inc. states

Filing text: “10b5-1 trading plan, adopted on April 18, 2024”

Sources: SEC EDGAR full-text search and the SEC submissions API.